NA
LMAT icon

NewEdge Advisors’s LeMaitre Vascular LMAT Stock Holding History

NewEdge Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Sell
2,307
-851
-27% -$81.1K ﹤0.01% 2463
2025
Q4 		$256K Buy
3,158
+139
+5% +$12K ﹤0.01% 2422
2025
Q3 		$264K Buy
3,019
+86
+3% +$7.68K ﹤0.01% 2256
2025
Q2 		$244K Buy
2,933
+2,641
+904% +$221K ﹤0.01% 2122
2025
Q1 		$24.5K Hold
292
– – ﹤0.01% 2793
2024
Q4 		$26.9K Hold
292
– – ﹤0.01% 2719
2024
Q3 		$27.1K Hold
292
– – ﹤0.01% 2630
2024
Q2 		$24K Sell
292
-79
-21% -$5.8K ﹤0.01% 2576
2024
Q1 		$24.6K Buy
371
+79
+27% +$4.88K ﹤0.01% 2561
2023
Q4 		$16.6K Buy
292
+257
+734% +$13.5K ﹤0.01% 2646
2023
Q3 		$1.91K Sell
35
-89
-72% -$5.27K ﹤0.01% 3062
2023
Q2 		$8.35K Buy
124
+33
+36% +$2.01K ﹤0.01% 2658
2023
Q1 		$4.69K Sell
91
-610
-87% -$29.6K ﹤0.01% 2799
2022
Q4 		$28.1K Buy
+701
New +$32.8K ﹤0.01% 1993

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NewEdge Advisors's LMAT Position: Q1 2026 in Review

NewEdge Advisors reduced its LeMaitre Vascular (LMAT) stake by 27% in Q1 2026, selling an estimated $81.1K and leaving 2,307 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

NewEdge Advisors first reported a position in LMAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $264K in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • NewEdge Advisors held 2,307 shares of LeMaitre Vascular worth $252K as of Q1 2026.
  • NewEdge Advisors sold 851 LeMaitre Vascular shares in Q1 2026, an estimated $81.1K.
  • LeMaitre Vascular made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2463 holding.
  • NewEdge Advisors first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 14 quarters since.
  • NewEdge Advisors's LeMaitre Vascular position peaked at $264K in Q3 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.